JHJAX
Price
$25.70
Change
+$0.03 (+0.12%)
Updated
Nov 12 closing price
VSTSX
Price
$284.01
Change
-$1.10 (-0.39%)
Updated
Nov 12 closing price
Ad is loading...

JHJAX vs VSTSX

Header iconJHJAX vs VSTSX Comparison
Open Charts JHJAX vs VSTSXBanner chart's image
JHancock ESG Large Cap Core A
Price$25.70
Change+$0.03 (+0.12%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$284.01
Change-$1.10 (-0.39%)
VolumeN/A
CapitalizationN/A
JHJAX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JHJAX vs. VSTSX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHJAX is a StrongBuy and VSTSX is a Buy.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.73T vs. JHJAX (150M). VSTSX pays higher dividends than JHJAX: VSTSX (1.36) vs JHJAX (0.48). JHJAX was incepted earlier than VSTSX: JHJAX (8 years) vs VSTSX (8 years). JHJAX is a more actively managed with annual turnover of: 12.00 vs. VSTSX (2.00). JHJAX has a lower initial minimum investment than VSTSX: JHJAX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 36.94 vs. JHJAX (29.98). VSTSX return over 5 years is better than : 90.06 vs. JHJAX (76.30).
JHJAXVSTSXJHJAX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years8 years-
Gain YTD20.42325.48080%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets150M1.73T0%
Annual Yield % from dividends0.481.3635%
Returns for 1 year29.9836.9481%
Returns for 3 years14.0123.4360%
Returns for 5 years76.3090.0685%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMRT1.540.02
+1.32%
SmartRent
WRAP1.530.01
+0.66%
Wrap Technologies
CHRW109.060.50
+0.46%
C.H. Robinson Worldwide
CALX33.27-0.27
-0.81%
CALIX
PHIO2.61-0.34
-11.53%
Phio Pharmaceuticals Corp